Literature DB >> 32509004

Influence of inflammation and adipocyte biochemical markers on the components of metabolic syndrome.

Dana Carmen Zaha1,2, Cosmin Vesa1,2, Diana Uivarosan1, Ovidiu Bratu3, Ovidiu Fratila4, Delia Mirela Tit5, Carmen Pantis2,6, Camelia C Diaconu7, Simona Bungau5.   

Abstract

Metabolic syndrome is associated with increased risk of cardiovascular disease. This study investigated the correlation between adipocyte and inflammation biomarkers, and metabolic syndrome and its components. The study included 80 patients with normal body-mass index and 80 obese patients. The groups were assessed for serum values of adiponectin, leptin and highly sensitive C reactive protein (hsCRP), the homeostatic model assessment of insulin resistance (HOMA-IR), as well as the influence of these biochemical markers on the prevalence of metabolic syndrome and its components. Leptin, HOMA-IR and hsCRP had statistically significant (P<0.01) higher values in the group of obese subjects, while adiponectin had statistically significant (P<0.01) lower values. The prevalence of metabolic syndrome was 35% in the obese group and 5% in the normal weight group. Adiponectin and HOMA-IR were the variables significantly associated with metabolic syndrome (P<0.01), adiponectin/HOMA-IR ratio and leptin/adiponectin ratio were also associated with metabolic syndrome (P<0.01). No relationship was found between metabolic syndrome and hsCRP. Adiponectin and adiponectin/HOMA-IR were associated with all the components of metabolic syndrome and they can be useful to identify patients with high risk of diabetes mellitus and cardiovascular disease.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  adipocyte biochemical markers; hsCRP; inflammation; leptin; metabolic syndrome

Year:  2020        PMID: 32509004      PMCID: PMC7271710          DOI: 10.3892/etm.2020.8663

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  5 in total

1.  Significant aspects and correlation between glycemic control and generalized chronic periodontitis in type 2 diabetes mellitus patients.

Authors:  Manuela Stoicescu; Horea Calniceanu; Ioan Țig; Sebastian Nemeth; Adriana Tent; Adelina Popa; Ciprian Brisc; Ioana Ignat-Romanul
Journal:  Exp Ther Med       Date:  2021-04-23       Impact factor: 2.447

2.  Manometric changes of the esophagus in morbidly obese patients.

Authors:  Andrada L Popescu; Raluca S Costache; Daniel O Costache; Vasile D Balaban; Mariana Jinga; Florentina Ionita-Radu; Ana Caruntu; Carmen Fierbinteanu-Braticevici
Journal:  Exp Ther Med       Date:  2021-04-14       Impact factor: 2.447

3.  The influence of diet therapeutic intervention on the sarcopenic index of patients with metabolic syndrome.

Authors:  T C Ghitea; S Vlad; D Birle; D M Tit; L Lazar; C Nistor-Cseppento; T Behl; S Bungau
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

4.  Authors' Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19.

Authors:  Bin Liu; Zhigang Qi
Journal:  Clin Drug Investig       Date:  2020-09       Impact factor: 2.859

Review 5.  Which BMI for Diabetes Patients is Better? From the View of the Adipose Tissue Macrophage-Derived Exosome.

Authors:  Hushan Ao; Tianjun Li; Xiaojie Liu; Haichen Chu; Yuzhi Ji; Zeljko Bosnjak
Journal:  Diabetes Metab Syndr Obes       Date:  2022-01-13       Impact factor: 3.168

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.